SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?


To: Walter Morton who wrote (368)9/15/1999 11:51:00 AM
From: Platter  Read Replies (1) | Respond to of 656
 
Cut in estimates today seems to have already been priced in......From Briefing.com,Immunex Corp. (IMNX) 47 1/8 -6 1/8: Donaldson, Lufkin, Jenrette lowers estimates on biopharmaceutical firm from $0.23 to $0.22 for FY99, FY00 from $1.17 to $0.99 and FY01 from $2.11 to $1.73 based on IMS prescription trends for Enbrel.....